Humacyte Stock Forecast

Buy candidate since May 21, 2026 Gain 37.25%

The Humacyte, Inc. stock price gained 0.719% on the last trading day (Wednesday, 3rd Jun 2026), rising from $1.39 to $1.40. During the last trading day the stock fluctuated 8.15% from a day low at $1.35 to a day high of $1.46. The price has risen in 9 of the last 10 days and is up by 69.64% over the past 2 weeks. Volume fell on the last day by -3 million shares and in total, 5 million shares were bought and sold for approximately $7.67 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.46 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 14.08% during the next 3 months and, with a 90% probability hold a price between $0.80 and $1.66 at the end of this 3-month period.

HUMA Signals & Forecast

The Humacyte, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.30 and $0.96. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -3.45%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Humacyte, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.28 and $1.15. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Humacyte, Inc. finds support just below today's level at $1.28. If this is broken, then the next support from accumulated volume will be at $1.15 and $1.13.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.110 between high and low, or 8.15%. For the last week, the stock has had daily average volatility of 11.33%.

Our recommended stop-loss: $1.34 (-4.46%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (HUMA) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Humacyte, Inc. to open at $1.40, and during the day (based on 14 day Average True Range), to move between $1.34 and $1.46, which gives a possible trading interval of +/-$0.118 (+/-8.80%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 8.80% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.45 (3.57%) than the support at $1.28 (8.57%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Humacyte, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Humacyte, Inc. stock to perform well in the short-term.

Current score: 1.651 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $1.40 ( 0.238%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk